Please login to the form below

Global communications during and post a worldwide pandemic: how can organisations break through the noise?

COVID-19 has understandably dominated the news agenda like no other story in a generation. But what about other disease areas that are both important and deserve public attention? How do we break through this wall, particularly as coronavirus looks set to govern the news agenda for the next few months at least, if not longer?

Zuzanna Grzeskiewicz, Account Director, Hanover

Large organisations and health-focused charities need to plan now to ensure their disease area of focus remains on the table. In many cases, plans made for 2020 need to be adapted. If we take a step back from the chaos and confusion, there are ample opportunities for our industry.

Embrace social and virtual

As the world stays at home more, in addition to holding your conferences online, highly targeted social media is key: disseminating messages to reach the right audiences at the right time, is more important than ever. We are seeing organisations which previously hesitated to use this platform starting to embrace it more, with great success.

Respond to the news agenda

During the pandemic, companies and charities need to be agile. It is worth exploring how your disease area has been affected: check-ups have been cancelled to free up health services across the globe, for example. Some charities have taken this as a chance to sensitively reiterate the importance of care in their field. In the UK, an example of this is Macmillan Cancer Support’s latest campaign.

In the pharmaceutical world, many are effectively emphasising solutions to alleviating burdens faced by health systems around the world. Examples of this include alternative therapeutic options available such as remote treatment, which has the potential to alleviate pressures on health services: a crucial concern of today’s media.

In other words, organisations need to ensure they are part of the global news agenda: not swept away by it.

Search for positivity

Positive non-coronavirus related news, we’ve found, is in high demand by the press. Organisations should consider this, and work with relevant contacts. It may not get you the front page during the height of the pandemic, but leading international outlets are made up of more than just the cover.

Looking to a post-pandemic world

What can large organisations do now to prepare to tell their story in a post-pandemic world? There will be a time when coronavirus is no longer front of mind. Organisations therefore need to plan ahead.

Today is the perfect time to craft your story; clarity in your mission, vision and values. Because in a post-pandemic world, values will be scrutinised. What did you do during the pandemic? How did you communicate this, is this aligned with your identity as a business? Did you build relationships that will help better patient outcomes? Get your story ready now and be ready to launch it as soon as the time is right.

As global communicators, we are skilled at adapting to trends and getting ahead of them. The worldwide pandemic, although a time of unprecedented uncertainty in our lifetimes, doesn’t change these fundamental principles.

13th May 2020


Company Details

Hanover Communications

+44 (0)20 7400 4480

Contact Website

Riverside House
Southwark Bridge House
United Kingdom

Latest content on this profile

Putting prevention at the heart of the future of the NHS
Prioritising the prevention of cardiovascular disease (CVD) should be at the heart of plans to safeguard the long-term sustainability of the NHS. Unfortunately, action in this area has to date not matched ambition, putting thousands of patients’ lives – and the future of the health system – at risk.
Hanover Communications
Action on Anti-microbial resistance: Will the UK rise to the challenge
Timely and effective antimicrobials are the cornerstone of our healthcare systems, providing life-saving treatment and supporting vital services like routine operations, transplants and cancer treatment. We are three years into the UK Government’s 20-Year Vision for Antimicrobial Resistance (AMR), and the Department of Health and Social Care recently launched a consultation for the next iteration of the AMR National Action Plan (2024-2029). However, latest figures show that AMR is still on the rise. Is UK policy ambitious enough to drive innovation in AMR, and is the Government on track to contain, control and mitigate AMR by 2040?
Hanover Communications
Winter and workforce woes: challenges facing the new Secretary of State for Health and Social Care
For the third time this year, the NHS and social care has a new Secretary of State. The appointment must now signal stability following a period of political turbulence, as we head into what health leaders are describing as the toughest winter to date. Backlogs, delayed discharges, ambulance and A&E pressures, and crumbling NHS estates will remain top of Steve Barclay’s priority list in the coming weeks and months ahead. However, he will also need to address the longstanding workforce issues that hold back both the NHS and social care sector. Only dealing with these structural challenges will ensure the health and care system is operationally fit for winters to come.
Hanover Communications
A new 10-year cancer plan: Will the government be able to deliver what the sector needs?
The Truss Government has committ­ed to developing a new 10-year cancer plan. But set against the backdrop of the Secretary of States priorities, what real value can the sector expect a new cancer plan to deliver? What questions need addressing to drive impactful change for patients? Will there be funding available to support the transformation?  We will explore the state of play of cancer care in England and assess the main priorities, including how they align with wider NHS challenges. We will set out the difficult choices that a new plan must confront to enable prioritisation of this complex disease area and consider the balance between taking action to impact patients now versus initiatives to benefit patients of the future.
Hanover Communications
Will the NHS be safe in Liz Truss’s Hands?
As expected, Liz Truss has been anointed as the new Prime Minister. One of her major challenges is the NHS and, with only two years to another general election, she does not have much time to restore falling public confidence in the service.
Hanover Communications
A new prescription for the U.S. healthcare market?
Last month the U.S. Government passed the Inflation Reduction Act, paving the way for unprecedented drug pricing reforms across the country. In a market with spiralling healthcare costs, and increasing stories of patients missing out, or rationing treatment, the Act is welcomed by many. But it’s also severely criticised by others, including representatives from the pharmaceutical industry who say it jeopardises future innovation and drug discovery. As the largest pharmaceuticals market, the impact of the legislation will be felt outside of the U.S., but what does this look like, in the short and long-term? Is it a proverbial drop in the ocean, or is a storm brewing?
Hanover Communications